Trials / Unknown
UnknownNCT00578825
A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 340 (estimated)
- Sponsor
- Hospital Authority, Hong Kong · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The study aims to examine whether the combination of Lopinavir/Ritonavir plus Ribavirin for treatment of severe acute respiratory syndrome (SARS) is superior to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lopinavir / Ritonavir plus Ribavirin |
Timeline
- First posted
- 2007-12-21
- Last updated
- 2013-08-22
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00578825. Inclusion in this directory is not an endorsement.